Steven Mortazavi, MD
Pain Medicine · Bethlehem, PANPI 1902805252
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,999 of the $6,443 with a category attached, or 62.1%. 32 manufacturers reported payments, led by Vertiflex, Inc. at 43.5% of the total. Reporting peaked in 2019 at $3,246 and has fallen 78.0% since, to $715 in 2025.
Across 199 payments — averaging $32.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertiflex, Inc.$3K
- Scilex Pharmaceuticals Inc.$757
- Collegium Pharmaceutical, Inc.$738
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$518
- Vertos Medical, Inc.$223
- Phathom Pharmaceuticals, Inc.$125
- plus $1K from 26 others
What the payments were for
- Travel & lodging$2,42338%
- Food & beverage$3,99962%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertiflex, Inc. | 14 | $2,801 |
| Scilex Pharmaceuticals Inc. | 35 | $757 |
| Collegium Pharmaceutical, Inc. | 54 | $738 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $518 |
| Vertos Medical, Inc. | 4 | $223 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Biodelivery Sciences International, Inc. | 7 | $121 |
| Si-bone, Inc. | 4 | $111 |
| Foundation Fusion Solutions, LLC | 4 | $103 |
| GRT US Holding, Inc. | 5 | $90 |
| Tersera Therapeutics LLC | 6 | $90 |
| Vertex | 3 | $87 |
| Globus Medical | 4 | $82 |
| Hikma Pharmaceuticals USA | 4 | $73 |
| AbbVie(2 entities) | 3 | $54 |
| Redhill Biopharma Inc. | 3 | $49 |
| Valinor Pharma, LLC | 2 | $43 |
| Medtronic | 1 | $39 |
| Eisai Inc. | 2 | $38 |
| Almatica Pharma LLC | 2 | $37 |
| Boston Scientific | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Kaleo, Inc. | 2 | $29 |
| Forte Bio-pharma LLC | 1 | $27 |
| Stimwave Technologies Incorporated | 1 | $25 |
| Averitas Pharma Inc. | 1 | $22 |
| ERMI LLC | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$2,550
- VOQUEZNA$125
How this compares
$6,443 in reported general payments places this provider in the 80th percentile of 294 pain medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Bethlehem
- Peter PryzbylkowskiPhiladelphia$506K
- Yeshvant NavalgundGreensburg$388K
- Jack SmithWilliamsport$324K
- Sanjay GuptaBala Cynwyd$241K
- Vwaire OrhurhuWilliamsport$191K
- Philip KimBryn Mawr$128K
- Ajay WasanPittsburgh$66K
- Sanjay ShahSpring House$64K
- Soon JungAllentown$58K
- Bruce NicholsonAllentown$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.